首頁 > 市場調查報告書 > 製藥

臨床開發

小鼠模型市場規模、佔有率及成長分析（依模型類型、技術、應用、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1913208

小鼠模型市場規模、佔有率及成長分析（依模型類型、技術、應用、最終用戶及地區分類）－2026-2033年產業預測

Mice Model Market Size, Share, and Growth Analysis, By Model Type (Inbred Mice, Outbred Mice), By Technology (CRISPR / Gene-Editing, Embryonic Stem Cell Injection), By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月01日 | 出版商:

SkyQuest | 英文 177 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球小鼠模型市場規模預計在 2024 年達到 17.1 億美元，從 2025 年的 18.2 億美元成長到 2033 年的 30.3 億美元，在預測期（2026-2033 年）內複合年成長率為 6.6%。

全球小鼠模型市場的成長主要受癌症、糖尿病和心血管疾病等慢性疾病發生率上升的驅動。隨著全球醫療體係日益重視早期檢測和創新療法，小鼠因其在遺傳、生物學和行為學上與人類的相似性，在臨床前試驗中扮演越來越重要的角色。為加速藥物研發而進行的大量研發投入進一步提升了對這些先進研究模型的需求。此外，基因工程技術的快速發展，特別是CRISPR-Cas9技術的進步，提高了建構高精度基因轉殖小鼠和基因敲除小鼠的能力。這些進步提高了臨床前試驗的準確性，減少了試驗失敗，進一步強化了基因工程小鼠在生物醫學研究和治療方法開發中的關鍵作用。

全球小鼠模型市場促進因素

慢性疾病（包括癌症、糖尿病和心血管疾病）的日益普及是全球小鼠模型市場擴張的主要驅動力。這些模型在理解疾病的潛在機制方面發揮關鍵作用，對於測試和評估新型治療性介入至關重要。它們在藥物研發過程中的重要性不容忽視，因為它們有助於快速開發創新治療方法，以滿足日益成長的有效醫療保健解決方案的需求。隨著研究人員繼續依賴小鼠模型為醫學研究做出寶貴貢獻，預計這些重要工具的市場將繼續保持成長勢頭。

限制全球小鼠模型市場的因素

全球小鼠模型市場面臨許多限制因素，其中最主要的是實驗室小鼠的繁殖、飼養和保育成本高。專業設施、合格人員以及嚴格的倫理準則要求顯著增加了營運成本。這種經濟負擔阻礙了小規模研究機構進入市場，並減緩了市場的整體成長，尤其是在新興地區。這些因素共同限制了關鍵資源和技術的獲取，最終影響了依賴小鼠模型進行各類科學研究的舉措的進展與拓展。

全球滑鼠模型市場趨勢

全球小鼠模型市場正呈現出一個顯著的趨勢，即製藥和生物技術公司擴大採用人源化和基因轉殖小鼠模型。這項轉變的驅動力在於需要更精確地模擬人類疾病狀態，以顯著提高臨床前試驗的預測準確性。隨著企業尋求改善藥物研發流程並降低臨床試驗失敗率，對先進小鼠模型的需求也不斷成長。這一趨勢反映了更廣泛的調查方法改善需求，最終將人源化和基因轉殖小鼠模型確立為推動創新治療方法和最佳化整個醫療保健領域開發成果的關鍵工具。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Charles River Laboratories
The Jackson Laboratory
Taconic Biosciences
Envigo
Janvier Labs
GenOway
Cyagen Biosciences
BioCytogen
InVivo Biosystems
Ozgene
Horizon Discovery
Crown Bioscience
The Jackson Laboratory for Genomic Medicine
GenOway SA
Transgenic Animal Model Technologies（TAMT）
Wuxi AppTec
LAB Research Models & Services
Biocytogen Pharma Technology
GeneChem Co., Ltd.
Shanghai Model Organism Center

結論與建議

簡介目錄

Product Code: SQMIG35H2381

Global Mice Model Market size was valued at USD 1.71 Billion in 2024 and is poised to grow from USD 1.82 Billion in 2025 to USD 3.03 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The Global Mice Model Market is primarily driven by the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. As healthcare systems globally focus on early detection and innovative treatments, the reliance on mice for preclinical trials has heightened due to their genetic, biological, and behavioral similarities to humans. This demand for advanced research models is further amplified by significant investments in R&D aimed at expediting drug discovery. Additionally, the rapid evolution of genetic engineering technologies, particularly CRISPR-Cas9, enhances the capability to produce highly precise transgenic and knockout mice. These advancements improve the accuracy of preclinical tests and reduce trial failures, reinforcing genetically engineered mice's essential role in enhancing biomedical research and therapeutic development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mice Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mice Model Market Segments Analysis

Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mice Model Market

The rising prevalence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases, significantly propels the expansion of the global mice model market. These models play a vital role in understanding the underlying mechanisms of diseases and are indispensable in testing and assessing new therapeutic interventions. Their importance in the drug discovery process cannot be overstated, as they facilitate the rapid development of innovative treatments that address the increasing need for effective healthcare solutions. As researchers continue to rely on mice models for their valuable contributions to medical research, the market for these essential tools is expected to continue its upward trajectory.

Restraints in the Global Mice Model Market

The global mice model market encounters significant limitations due to the elevated expenses associated with the breeding, maintenance, and housing of laboratory mice. The need for specialized facilities, qualified personnel, and adherence to strict ethical guidelines leads to substantial operational costs. This financial burden creates barriers for smaller research institutions, hindering their ability to participate in the market and slowing overall growth, especially in emerging regions. These factors collectively restrict access to essential resources and technologies, ultimately affecting the progress and expansion of research initiatives reliant on mice models for various scientific studies.

Market Trends of the Global Mice Model Market

The Global Mice Model market is experiencing a notable trend towards the increasing adoption of humanized and transgenic mice models among pharmaceutical and biotech companies. This shift is driven by the need for more accurate replication of human disease conditions, which significantly improves the predictive value of preclinical studies. As companies seek to enhance drug discovery processes and minimize clinical trial failures, the demand for sophisticated mice models is escalating. This trend reflects a broader push for precision in research methodologies, ultimately positioning humanized and transgenic models as vital tools in advancing innovative therapeutics and optimizing developmental outcomes across the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Assessment
Regulatory Landscape

Global Mice Model Market Size by Model Type & CAGR (2026-2033)

Market Overview
Inbred Mice
Outbred Mice
Genetically Engineered Mice (GEM)
Hybrid / Congenic Mice

Global Mice Model Market Size by Technology & CAGR (2026-2033)

Market Overview
CRISPR / Gene-Editing
Embryonic Stem Cell Injection
Microinjection / Nuclear Transfer
Traditional Breeding & Rederivation

Global Mice Model Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery & Development
Disease Modeling (Oncology, Immunology, Neurology, Metabolic)
Toxicology & Safety Pharmacology
Personalized / Translational Research

Global Mice Model Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organisations (CROs)
Government & Regulatory Agencies

Global Mice Model Market Size & CAGR (2026-2033)

North America (Model Type, Technology, Application, End-User)
- US
- Canada
Europe (Model Type, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Model Type, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Model Type, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Model Type, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Jackson Laboratory
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taconic Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Envigo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Janvier Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenOway
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCytogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InVivo Biosystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ozgene
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Discovery
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crown Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Jackson Laboratory for Genomic Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenOway SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transgenic Animal Model Technologies (TAMT)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi AppTec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LAB Research Models & Services
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocytogen Pharma Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneChem Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Model Organism Center
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments